SCHEMBL9915224

SCHEMBL9915224

CC/N=C/c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.55
MAOA P21397 2/20 0.53
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
ATM Q13315 1/20 0.52
TOP2A P11388 2/20 0.50
ALDH1A1 P00352 2/20 0.49
G6PC1 P35575 1/20 0.49
PKM P14618 1/20 0.49
USP2 O75604 1/20 0.49
MAOB P27338 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
CTH P32929 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
PTBP1 P26599 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3109223 1.00 NR4A1 (0.55) NR4A1MAOANPC1RAB9AMEN1
SCHEMBL74245 0.85 NR4A1 (0.52) NR4A1MAOANPC1RAB9AMEN1
SCHEMBL10308820 0.85 NR4A1 (0.52) NR4A1MAOANPC1RAB9AMEN1
SCHEMBL4250235 0.83 NR4A1 (0.59) NR4A1MAOANPC1RAB9AMEN1
SCHEMBL4250239 0.83 NR4A1 (0.59) NR4A1MAOANPC1RAB9AMEN1
SCHEMBL6334411 0.82 CYP1A2 (0.51) NR4A1MAOANPC1RAB9AMEN1
SCHEMBL9261403 0.82 CYP1A2 (0.51) NR4A1MAOANPC1RAB9AMEN1
Bromide SCHEMBL4891392 0.82 NR4A1 (0.49) NR4A1MAOANPC1RAB9AMEN1
SCHEMBL832503 0.80 CYP1A2 (0.53) NR4A1MAOANPC1RAB9AMEN1
SCHEMBL832504 0.80 CYP1A2 (0.53) NR4A1MAOANPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9862906-B2 Base oils and methods for making the same Amyris, Inc. (US) 2018-01-09 US disclosed
US-9533297-B2 Ligands designed to provide highly active catalyst complexes CARNEGIE MELLON UNIVERSITY (US) 2017-01-03 US disclosed
US-9200104-B2 Polymer WARWICK EFFECT POLYMERS LIMITED (GB) 2015-12-01 US disclosed
US-9200104-B2 Polymer WARWICK EFFECT POLYMERS LIMITED (GB) 2015-12-01 US disclosed
US-20150087795-A1 LIGANDS DESIGNED TO PROVIDE HIGHLY ACTIVE CATALYST COMPLEXES CARNEGIE MELLON UNIVERSITY 2015-03-26 US disclosed
US-8846919-B2 Azaallyl-containing moieties as chelate for metals CORNELL UNIVERSITY (US) 2014-09-30 US disclosed
US-20140221258-A1 BASE OILS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2014-08-07 US disclosed
US-20130295040-A1 POLYMER WARWICK EFFECT POLYMERS LTD (US) 2013-11-07 US disclosed
US-20130295040-A1 POLYMER WARWICK EFFECT POLYMERS LTD (US) 2013-11-07 US disclosed
US-8420802-B2 Polymer support UNIVERSITY OF CAPE TOWN (ZA) 2013-04-16 US disclosed
US-20120178916-A1 Polymer Support UNIVERSITY OF CAPE TOWN (ZA) 2012-07-12 US disclosed
US-8197847-B2 Process for making polymers and supports comprising pendant sugar side groups WARWICK EFFECT POLYMERS LTD. (GB) 2012-06-12 US disclosed
US-20100204473-A1 Azaallyl-Containing Moieties As Chelate For Metals CORNELL UNIVERSITY (US) 2010-08-12 US disclosed
US-20090082224-A1 POLYMERS WARWICK EFFECT POLYMERS LIMITED (GB) 2009-03-26 US disclosed
US-20080300348-A1 Polymer WARWICK EFFECT POLYMERS LIMITED 2008-12-04 US disclosed
US-20070219330-A1 Amide initiators WARWICK EFFECT POLYMERS LIMITED (GB) 2007-09-20 US disclosed
WO-2007083097-A1 LIVING RADICAL POLYMERISATION PROCESS WARWICK EFFECT POLYMERS LTD. (GB) 2007-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221258-A1 BASE OILS AND METHODS FOR MAKING THE SAME OSBP, OSBPL8, FDFT1 NR4A1 3736/4885MAOA 4359/4885NPC1 259/4885
US-20130295040-A1 POLYMER PCNA, PARG, COASY NR4A1 3872/4885MAOA 3764/4885NPC1 4425/4885
US-20100204473-A1 Azaallyl-Containing Moieties As Chelate For Metals AZI2, SLC30A6, SLC39A3 NR4A1 353/4885MAOA 525/4885NPC1 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.